Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Project of a new organization of our establishments in France



The development of regulation applicable to homeopathy in France during the last years causes the fall-off in sales of mother tinctures and the progressive reduction of prescribed specific medications.


We were therefore led to present today to the concerned employees and staff representatives, a project of a new organization of our establishments in France. This project will be discussed in the coming weeks.


 


 


Our next update: January 26, 2017 at market close, publication of the sales revenue for the year 2016.

Person responsible for financial information: Christian Boiron

Contact for financial information: Véronique Bouscayrol

Investor relations: +33 (0) 4.78.45.63.43 - e-mail : [email protected]

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at: www.boironfinance.com




Regulated information

News releases under ongoing reporting obligations:

- other releases

Full and original press release in PDF:


https://www.actusnews.com/documents_communiques/ACTUS-0-46422-cp-boiron_151116.pdf


Receive by email the next press releases of the company by registering on
www.actusnews.com, it's free



Source: Actusnews

Boiron S.A. Stock

€32.50
-0.460%
Boiron S.A. shows a slight decrease today, losing -€0.150 (-0.460%) compared to yesterday.

Like: 0
Share

Comments